IQ-AI AI Stock Analysis
IQ-AI (5Y1) AI Stock Analysis
IQ-AI
(Frankfurt:5Y1)
No summary available
IQ-AI (5Y1) vs. iShares MSCI Germany ETF (EWG)
Not enough price history over this period.
- Market Cap
- EUR 1.79M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -7.3
- Beta (1Y)
- 0.42
- Revenue Growth
- 12.02%
- EPS Growth
- -57.14%
- Country
- Germany
- Employees
- 7
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
IQ-AI Business Overview & Revenue Model
Company Description
Imaging Biometrics Ltd., founded in 1965 and headquartered in Saint Helier, Jersey, specializes in medical imaging diagnostics and clinical patient care. The company extends its services across the United Kingdom, Switzerland, the European Union, and...
IQ-AI Peers Comparison
Overall Rating
GB:IXI55Neutral
GB:GDR49Neutral
GB:RENX44Neutral
GB:COG41Neutral
GB:OBD40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 55Neutral | GBP 27.92M | -6.50 | -16.18% | ― | 13.04% | 15.88% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 49Neutral | GBP 14.45M | -0.82 | -1044.57% | ― | 65.60% | 74.84% | |
| 44Neutral | GBP 36.20M | -3.36 | 675.00% | ― | ― | ― | |
| 41Neutral | GBP 15.65M | -9.63 | -54.17% | ― | 11.86% | 23.81% | |
| 40Underperform | GBP 15.46M | -0.29 | -451.74% | ― | 33.37% | 86.41% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:5Y1 | IQ-AI Limited | ― | ― | ― | |
| GB:COG | Cambridge Cognition Holdings | 29.00 | -4.00 | -12.12% | |
| GB:GDR | Genedrive plc | 0.90 | 0.11 | 13.92% | |
| GB:IXI | IXICO plc | 12.75 | 1.50 | 13.33% | |
| GB:OBD | Oxford BioDynamics | 0.12 | -0.17 | -58.93% | |
| GB:RENX | Renalytix Plc OTC | 5.40 | -1.85 | -25.52% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
